The Business & Finance working group focuses its efforts on improving the business and financial environment for life science research and entrepreneurship. The members are leading professionals such as CEOs and CFOs with a background from both the industry and the financial community. They all share an interest and commitment to the growth potential within the life science sector.
Members
|
Name |
Position |
Company |
|
|
|
| Erik Walldén (Chairman) |
CEO |
Gyros |
| Hans Andreasson |
Investment Director |
SLS Invest |
| Gunnar Fernström |
Investment Director |
InnovationsKapital |
| Jacob Gunterberg |
Partner |
HealthCap |
| Anna Gustafsson |
Investment Manager |
SEB Venture Capital |
| Lennart Hansson |
Investment Director |
Industrifonden |
| Ingemar Lagerlöf |
CEO |
LinkMed |
| Anna Levander |
Commercial Director |
Abbott |
| Yvonne Mårtensson |
CEO |
CellaVision |
| Paul de Potocki |
CEO |
Aerocrine |
| Jonas Ekstrand |
Senior Manager |
SwedenBIO |
Goals
- Adapt the Swedish taxation system to better stimulate innovation and investments in advanced life science research by a Swedish R&D tax incentive
- Support the business development among the member companies by organizing investment events and partnering seminars with leading industrial players
- Develop the skills and insights among the member companies, vital to the growth and sustainable expansion of life science companies